Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1982-11-03
1989-09-19
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548207, A61K 31425, C07D27506
Patent
active
048681881
ABSTRACT:
Novel 4-(benzisothiazol-3-yl)phenoxyacetic acid 1',1'-dioxides of the formula ##STR1## where X is hydrogen, halogen or loweralkyl; R.sub.1 is hydrogen or loweralkyl; R.sub.2 and R.sub.3 are each independently Cl, Br or CH.sub.3, and related compounds, methods for preparing same and methods of treatment by administering compositions containing such a compound are described. These compounds are useful as diuretics.
REFERENCES:
patent: 3897476 (1975-07-01), Feit et al.
patent: 4017632 (1977-04-01), Nachmias et al.
patent: 4337261 (1982-06-01), Shutske et al.
patent: 4667041 (1987-05-01), Salzburg
patent: 4728662 (1988-03-01), Shutske
Boshagen et al., "Oxidation products of 3-Amino-1,2-Benzothiazoles . . . ," Chem. Ber. 103:3166-81, (1970).
Beeson et al., Textbook of Medicine, vol. II, 14th Ed., W. B. Saunders, Philadelphia, (1975), pp. 990-991.
Daus Donald G.
Hoechst-Roussel Pharmaceuticals Inc.
Ikeda Tatsuya
LandOfFree
4-(Benzisothiazol-3-yl)phenoxyacetic acid 1',1'-dioxides as diur does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(Benzisothiazol-3-yl)phenoxyacetic acid 1',1'-dioxides as diur, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(Benzisothiazol-3-yl)phenoxyacetic acid 1',1'-dioxides as diur will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-368905